Janus Henderson Group
ATRS

Janus Henderson Group’s Antares Pharma, Inc. ATRS Stock Holding History

Janus Henderson Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,202
Closed -$131K – 2749
2022
Q1 		$131K Sell
32,202
-117,730
-79% -$427K ﹤0.01% 2524
2021
Q4 		$535K Buy
149,932
+8,622
+6% +$30.2K ﹤0.01% 1854
2021
Q3 		$514K Sell
141,310
-34,658
-20% -$140K ﹤0.01% 1606
2021
Q2 		$767K Buy
+175,968
New +$717K ﹤0.01% 1362

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Janus Henderson Group's ATRS Position: Q2 2022 in Review

Janus Henderson Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 32,202 shares — an estimated $131K sold.

Janus Henderson Group first reported a position in ATRS in Q2 2021 and held it in 4 quarters. The position peaked at $767K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Janus Henderson Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Janus Henderson Group sold 32,202 Antares Pharma, Inc. shares in Q2 2022, an estimated $131K.
  • Janus Henderson Group first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 4 quarters.
  • Janus Henderson Group's Antares Pharma, Inc. position peaked at $767K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.